Kelly Welsh is an associate in the Washington, D.C. office of Latham & Watkins and a member of the Intellectual Property Litigation Practice.
Kelly represents clients in a range of intellectual property disputes, primarily in the life sciences and pharmaceutical industries.
She maintains an active pro bono practice, representing individuals seeking asylum, securing trademark protection for nonprofit organizations, and advocating for students with disabilities and their families to secure appropriate individualized education programs (IEPs) along with related services under the Individuals with Disabilities Education Act (IDEA).
Prior to joining Latham, Kelly worked at a boutique intellectual property law firm assisting individuals and small entities with patent and trademark prosecution before the United States Patent and Trademark Office.
During law school, Kelly served on the executive board for the American University Law Review as the Senior Federal Circuit Editor and published a comment titled "Institution Denied: The Evolution of Discretionary Denials of Inter Partes Review Under 35 U.S.C. § 314(a) Since Apple Inc. v. Fintiv, Inc."
Before attending law school, Kelly taught middle school math and science to students with disabilities through Teach For America in Crown Heights, Brooklyn, New York.
Experience
Kelly’s recent experience includes representing:
Avadel Pharmaceuticals in a series of patent litigations brought by Jazz Pharmaceuticals involving Avadel’s once-nightly narcolepsy drug LUMRYZ®; securing a precedential Federal Circuit ruling reversing and vacating an injunction that restricted Avadel’s clinical and regulatory activities for idiopathic hypersomnia, a win recognized by LMG Life Sciences as its 2025 Impact Case of the Year
AbbVie in Hatch-Waxman patent litigation involving RINVOQ®; secured favorable settlements with all generic manufacturers, a result recognized by The American Lawyer’sLitigation Daily with Litigators of the Week honors
Qualifications
Bar Qualification
District of Columbia
US Patent and Trademark Office
Education
JD, American University Washington College of Law, 2023 summa cum laude, Order of the Coif
MS in Education, Brooklyn College, 2015
BS in Biology & Psychology, Georgetown University, 2013
A Latham team led by David Frazier won the “Litigators of the Week” competition, alongside co-counsel at Covington, for their outstanding representation of AbbVie in securing the latest of five patent litigation settlements with generic makers that are set to protect its blockbuster immunology drug Rinvoq until 2037.
Notice: We appreciate your interest in Latham & Watkins. If your inquiry relates to a legal matter and you are not already a current client of the firm, please do not transmit any confidential information to us. Before taking on a representation, we must determine whether we are in a position to assist you and agree on the terms and conditions of engagement with you. Until we have completed such steps, we will not be deemed to have a lawyer-client relationship with you, and will have no duty to keep confidential the information we receive from you. Thank you for your understanding.